Rizatriptan Benzoate Tablets are mainly used for the treatment of migraine attacks in adults or children aged 6 to 17 years, etc. Rizatriptan Benzoate Tablets, whose main ingredient is Rizatriptan Benzoate, selectively constricts the cerebral vasculature system and has a weak effect on peripheral blood vessels, and is indicated for the acute treatment of migraine attacks in adults or children 6 to 17 years of age. Rizatriptan benzoate tablets are not indicated for the prophylaxis of migraine and for patients with hemiplegic or basilar migraine. Some patients taking rizatriptan benzoate tablets may experience adverse reactions such as chills, palpitations, flushing, facial puffiness, abdominal distension, and in some patients, nervousness, dullness of sensation, and memory loss. Patients who are allergic to the ingredients of rizatriptan benzoate, or have ischemic heart disease, peripheral vascular disease, hypertension and other diseases are prohibited from taking this drug. It is recommended that patients strictly follow the doctor’s instructions to use the drug, do not change the dose of the drug without authorization or abuse the drug privately, pay attention to observe the drug reaction in life, and consult a doctor in time if there is any abnormality.